Cochlear implants are designed to treat sensorineural hearing loss, the type caused by damage to the tiny hair cells inside the inner ear. Unlike hearing aids, which amplify sound, a cochlear implant bypasses the damaged parts of the ear entirely and sends electrical signals directly to the auditory nerve. This makes them the primary option when hearing aids no longer provide enough benefit.
How Sensorineural Hearing Loss Differs
There are two broad categories of hearing loss. Conductive hearing loss involves a mechanical problem in the outer or middle ear, something blocking or disrupting sound waves before they reach the inner ear. Sensorineural hearing loss happens deeper inside, where the cochlea’s hair cells are damaged or missing. These hair cells are responsible for converting sound vibrations into electrical signals the brain can interpret. When enough of them are destroyed, no amount of amplified sound can compensate.
Common causes of sensorineural hearing loss include aging, prolonged noise exposure, genetics, certain medications, and infections like bacterial meningitis. Meningitis is a particularly urgent cause in children: roughly 4% to 10% of survivors develop severe-to-profound hearing loss, often in both ears, and the cochlea can begin to ossify (harden with bone) afterward, narrowing the window for successful implantation.
Severity Thresholds for Candidacy
Not everyone with sensorineural hearing loss qualifies for a cochlear implant. The loss generally needs to be severe to profound, meaning you’re missing a substantial portion of speech even with well-fitted hearing aids.
For children, current guidelines typically require profound bilateral sensorineural hearing loss, with thresholds of 90 decibels (dB) or greater. However, research published in JAMA Otolaryngology suggests that children with hearing thresholds as low as 80 dB could also benefit from implantation, which is lower than most manufacturer guidelines currently recommend. In practice, pediatric candidacy also depends on demonstrating minimal benefit from conventional hearing aids.
For adults, Medicare covers cochlear implantation for moderate-to-profound sensorineural hearing loss when the patient scores 60% or lower on a sentence recognition test performed with hearing aids at their best settings. That score reflects how well you understand everyday speech in a realistic listening situation. If you’re catching less than 60% of sentences even with optimized hearing aids, you fall within the coverage criteria.
Why an Intact Auditory Nerve Matters
A cochlear implant works by stimulating the surviving nerve cells (spiral ganglion cells) that connect the cochlea to the brain. If the auditory nerve itself is absent or severely damaged, there’s nothing for the implant to stimulate. Surgeons can test nerve function during the procedure by measuring electrical responses from the brainstem. If no response is detected and imaging confirms the nerve is absent, the surgery may be stopped without placing the implant.
A small number of anatomical conditions make implantation impossible. Michel deformity, a rare condition where the cochlea and vestibular structures never develop at all, is one. Complete cochlear aplasia, the total absence of the cochlea, historically ruled out implantation as well. For these patients, an auditory brainstem implant, which bypasses the cochlea and auditory nerve entirely, is the alternative.
Single-Sided Deafness
Cochlear implants are increasingly used for single-sided deafness, where one ear has normal hearing and the other has profound loss. Traditional options like routing devices (which send sound from the deaf side to the hearing ear) can help with awareness but don’t restore true binaural hearing. A cochlear implant in the deaf ear is the only option that gives the brain input from both sides, which is critical for locating where sounds come from.
Studies show meaningful results. Patients who received implants for single-sided deafness reduced their sound localization error to about 15 degrees, compared to roughly 34 to 40 degrees with other devices. Speech understanding also improved significantly, with average gains of 28% on word recognition and 40% on sentence recognition. Tinnitus, which commonly accompanies single-sided deafness, improved in the majority of patients studied. One study of 22 patients found tinnitus was completely suppressed in three, improved in 18, and unchanged in only one.
Outcomes are better for people who lost hearing in that ear after learning to speak. Those with lifelong single-sided deafness, particularly from birth, show less improvement in sound localization, likely because the brain never developed the pathways needed to process input from that ear. Long-standing single-sided deafness of many years may also limit results.
High-Frequency Hearing Loss and Hybrid Implants
Some people have a pattern where low-frequency hearing is relatively intact but high-frequency hearing is severely impaired. High frequencies carry the consonant sounds that make speech intelligible, so this pattern can make conversations frustrating even when you can hear that someone is talking. Standard hearing aids often struggle to restore clarity in this range.
Hybrid cochlear implants were developed for exactly this situation. They combine a shorter electrode that stimulates the high-frequency region of the cochlea with acoustic amplification for the low frequencies you can still hear naturally. Candidacy for a hybrid device typically requires severe high-frequency sensorineural loss (75 dB or greater averaged across the higher pitches) with residual low-frequency hearing of 60 dB or better, and word recognition scores between 10% and 60% in the ear to be implanted. People whose severe hearing loss began before age two or who have had profound loss for more than 30 years are generally not candidates for this specific approach.
The FDA-Approved Age Minimum
The FDA has approved cochlear implants for children as young as nine months for some devices, though the most widely referenced threshold is 12 months. For certain devices, the approved minimum is 18 months with profound bilateral sensorineural hearing loss of 90 dB or greater. Early implantation matters enormously for language development. Children implanted in the first two years of life consistently develop stronger speech and language skills than those implanted later, because the brain’s ability to organize around sound input is strongest during this window.
Pediatric candidacy always includes a trial period with hearing aids to confirm they aren’t providing adequate benefit. For very young children, this trial is kept short to avoid unnecessary delay during the critical language-learning period.
Conditions That Have Been Reconsidered
The list of who can receive a cochlear implant has expanded considerably over the past few decades. Conditions once considered absolute disqualifiers, including chronic ear infections, inner ear malformations, cochlear ossification from meningitis, residual hearing, and older age, have all been successfully managed with modern surgical techniques and electrode designs. Even significant psychiatric conditions and cognitive impairment, once blanket exclusions, are now evaluated on a case-by-case basis rather than treated as automatic barriers. The few remaining hard contraindications are rare anatomical absences like Michel deformity and untreated masses within the skull.